R REGN

Regeneron Pharmaceuticals Inc

BIOTECHNOLOGY · HEALTHCARE

Regeneron Pharmaceuticals, Inc. is a prominent American biotechnology firm headquartered in Westchester County, New York, renowned for its pioneering work in monoclonal antibodies and therapeutic proteins. The company excels in various therapeutic areas, notably oncology, ophthalmology, and immunolo...

$790.81

+1.17% (+$9.14)

Volume 793,325

52W High $821.11

52W Low $476.49

Market Cap $60.54B

← Back to Calendar Compare with Others →

Next Earnings Report

Last Reported

Jan 30, 2026 Beat

Actual: $11.44 vs. Consensus: $10.52

Price Chart

EPS History: Consensus vs Actual

Last 12 quarters

Price Movement Around Earnings

Q4 2025 Jan 30, 2026

5-Day: +4.53%

Q3 2025 Oct 30, 2025

1-Day: -0.34%

5-Day: -3.98%

Q2 2025 Aug 1, 2025

5-Day: -0.67%

Q1 2025 Apr 29, 2025

1-Day: +5.25%

Revenue & Financial Performance

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q4'25	$3.88B	+2.5%	85.0%	22.7%	$844.6M
Q3'25	$3.75B	+0.9%	86.1%	27.4%	$1.46B
Q2'25	$3.68B	+3.6%	85.6%	29.4%	$1.39B
Q1'25	$3.03B	-3.7%	84.7%	19.5%	$808.7M
Q4'24	$3.79B	+10.3%	85.1%	26.1%	$917.7M
Q3'24	$3.72B	+10.7%	86.8%	31.7%	$1.34B
Q2'24	$3.55B	+12.3%	86.5%	30.2%	$1.43B
Q1'24	$3.15B	-0.5%	86.2%	23.9%	$722.0M

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q4 2025	Jan 30, 2026	$10.52	$11.82	$11.44	+8.75%	Missed
Q3 2025	Oct 30, 2025	$9.67	$10.40	$11.83	+22.34%	Beat
Q2 2025	Aug 1, 2025	$8.44	$8.80	$12.89	+52.73%	Beat
Q1 2025	Apr 29, 2025	$8.48	$8.80	$8.22	-3.07%	Missed
Q4 2024	Feb 4, 2025	$11.19	$11.63	$12.07	+7.86%	Beat
Q3 2024	Oct 31, 2024	$11.70	$12.26	$12.46	+6.50%	Beat
Q2 2024	Aug 1, 2024	$10.61	$11.11	$11.56	+8.95%	Beat
Q1 2024	May 2, 2024	$10.09	$10.55	$9.55	-5.35%	Missed
Q4 2023	Feb 2, 2024	$10.73	$11.37	$11.86	+10.53%	Beat
Q3 2023	Nov 2, 2023	$10.72	$11.43	$11.59	+8.12%	Beat
Q2 2023	Aug 3, 2023	$9.84	$10.62	$10.24	+4.07%	Missed
Q1 2023	May 4, 2023	$9.56	$10.17	$10.09	+5.54%	Met